Bioactive compound reveals a novel function for ribosomal protein S5 in hepatic stellate cell activation and hepatic fibrosis

Hepatology

Volumn 60, Issue 2, 2014, Pages 648-660

  Xu, Wei Heng ^a   Hu, Hong Gang ^a   Tian, Yuan ^a   Wang, Shao Zhan ^a   Li, Jie ^b   Li, Jian Zhong ^a   Deng, Xing ^c   Qian, Hui ^c   Qiu, Lei ^a   Hu, Zhen Lin ^a   Wu, Qiu Ye ^a   Chai, Yi Feng ^a   Guo, Cheng ^b   Xie, Wei Fen ^c   Zhang, Jun Ping ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

(6A,10,11A,11B,11C) 10 METHYLAMINO DODECAHYDRO 3A,7A DIAZABENZO[DE]ANTHRACENE 8 THIONE; ANTHRACENE DERIVATIVE; ANTIFIBROTIC AGENT; DIMETHYLNITROSAMINE; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE B; RIBOSOMAL PROTEIN S5; RIBOSOME PROTEIN; SERINE; THREONINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; DEPHOSPHORYLATION; DISEASE COURSE; ENZYME PHOSPHORYLATION; EXPERIMENTAL LIVER FIBROSIS; FIBROGENESIS; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER; LIVER CIRRHOSIS; MALE; MODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; REDUCTION; STELLATE CELL;

ADENOVIRIDAE; ALKALOIDS; ANIMALS; CELL LINE, TRANSFORMED; DISEASE MODELS, ANIMAL; GENE KNOCKDOWN TECHNIQUES; HEPATIC STELLATE CELLS; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; LIVER CIRRHOSIS; MALE; MEDICINE, CHINESE TRADITIONAL; MYOFIBROBLASTS; PHOSPHORYLATION; PRIMARY CELL CULTURE; QUINOLIZINES; RATS; RATS, SPRAGUE-DAWLEY; RIBOSOMAL PROTEINS; SIGNAL TRANSDUCTION;

EID: 84904689952     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27138     Document Type: Article

References (34)

1. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-172.
2. Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 2011;25:195-206.
3. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-1669.
4. De Minicis S, Seki E, Uchinami H, Kluwe J, Zhang Y, Brenner DA, et al. Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology 2007;132:1937-1946.
5. Rippe RA, Brenner DA. From quiescence to activation: gene regulation in hepatic stellate cells. Gastroenterology 2004;127:1260-1262.
6. Terstappen GC, Schlupen C, Raggiaschi R, Gaviraghi G. Target deconvolution strategies in drug discovery. Nat Rev Drug Discov 2007;6:891-903.
7. Hong MH, Lee JY, Jung H, Jin DH, Go HY, Kim JH, et al. Sophora flavescens Aiton inhibits the production of pro-inflammatory cytokines through inhibition of the NF kappaB/IkappaB signal pathway in human mast cell line (HMC-1). Toxicol In Vitro 2009;23:251-258.
8. Cheng H, Xia B, Zhang L, Zhou F, Zhang YX, Ye M, et al. Matrine improves 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis in mice. Pharmacol Res 2006;53:202-208.
9. Hu ZL, Zhang JP, Wan MB, Yu XB, Lin W, Qian DH. [Effect of matrine on mouse hepatitis and tumor necrosis factor production induced by Propionibacterium acnes/lipopolysaccharides.] Yao Xue Xue Bao 1996;31:662-665.
10. Hu ZL, Zhang JP, Yu XB, Lin W, Qian DH, Wan MB. Effect of matrine on lipopolysaccharides/D-galactosamine-induced hepatitis and tumor necrosis factor release from macrophages in vitro. Zhongguo Yao Li Xue Bao 1996;17:351-353.
11. Zhang JP, Zhang M, Zhou JP, Liu FT, Zhou B, Xie WF, et al. Antifibrotic effects of matrine on in vitro and in vivo models of liver fibrosis in rats. Acta Pharmacol Sin 2001;22:183-186.
12. Hu H, Wang S, Zhang C, Wang L, Ding L, Zhang J, et al. Synthesis and in vitro inhibitory activity of matrine derivatives towards pro-inflammatory cytokines. Bioorg Med Chem Lett 2010;20:7537-7539.
13. Yue HY, Yin C, Hou JL, Zeng X, Chen YX, Zhong W, et al. Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats. Gut 2010;59:236-246.
14. Zhong W, Shen WF, Ning BF, Hu PF, Lin Y, Yue HY, et al. Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats. Hepatology 2009;50:1524-1536.
15. Hu Z, Qiu L, Xiao Z, Wang J, Yu Q, Li J, et al. Effects of esculentoside A on autoimmune syndrome induced by Campylobacterjejuni in mice and its modulation on T-lymphocyte proliferation and apoptosis. Int Immunopharmacol 2010;10:65-71.
16. Yamamoto K, Yamazaki A, Takeuchi M, Tanaka A. A versatile method of identifying specific binding proteins on affinity resins. Anal Biochem 2006;352:15-23.
17. Garcia L, Hernandez I, Sandoval A, Salazar A, Garcia J, Vera J, et al. Pirfenidone effectively reverses experimental liver fibrosis. J Hepatol 2002;37:797-805.
18. Reif S, Lang A, Lindquist JN, Yata Y, Gabele E, Scanga A, et al. The role of focal adhesion kinase-phosphatidylinositol 3-kinase-Akt signaling in hepatic stellate cell proliferation and type I collagen expression. J Biol Chem 2003;278:8083-8090.
19. Gabele E, Reif S, Tsukada S, Bataller R, Yata Y, Morris T, et al. The role of p70S6K in hepatic stellate cell collagen gene expression and cell proliferation. J Biol Chem 2005;280:13374-13382.
20. Kordes C, Sawitza I, Haussinger D. Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells. Biochem Biophys Res Commun 2008;367:116-123.
21. Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 2002;14:381-395.
22. Lindsley CW. The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation: a 2009 update. Curr Top Med Chem 2010;10:458-477.
23. Warner JR, McIntosh KB. How common are extraribosomal functions of ribosomal proteins? Mol Cell 2009;34:3-11.
24. Lindstrom MS. Emerging functions of ribosomal proteins in gene-specific transcription and translation. Biochem Biophys Res Commun 2009;379:167-170.
25. Fukushi S, Okada M, Stahl J, Kageyama T, Hoshino FB, Katayama K. Ribosomal protein S5 interacts with the internal ribosomal entry site of hepatitis C virus. J Biol Chem 2001;276:20824-20826.
26. Pfingsten JS, Costantino DA, Kieft JS. Structural basis for ribosome recruitment and manipulation by a viral IRES RNA. Science 2006;314:1450-1454.
27. Schuler M, Connell SR, Lescoute A, Giesebrecht J, Dabrowski M, Schroeer B, et al. Structure of the ribosome-bound cricket paralysis virus IRES RNA. Nat Struct Mol Biol 2006;13:1092-1096.
28. Matragkou C, Papachristou H, Karetsou Z, Papadopoulos G, Papamarcaki T, Vizirianakis IS, et al. On the intracellular trafficking of mouse S5 ribosomal protein from cytoplasm to nucleoli. J Mol Biol 2009;392:1192-1204.
29. Tsiftsoglou AS, Wong W, Volloch V, Gusella J, Housman D. Commitment of murine erythroleukemia (MEL) cells to terminal differentiation is associated with coordinated expression of globin and ribosomal genes. Prog Clin Biol Res 1982;102 pt A:69-79.
30. Vizirianakis IS, Pappas IS, Gougoumas D, Tsiftsoglou AS. Expression of ribosomal protein S5 cloned gene during differentiation and apoptosis in murine erythroleukemia (MEL) cells. Oncol Res 1999;11:409-419.
31. Aleixo AA, Michelin MA, Murta EF. Immunotherapy with dendritic cells as a cancer treatment: perspectives and therapeutic potential. Recent Pat Endocr Metab Immune Drug Discov 2013;7:226-232.
32. Liu XJ, Yang L, Luo FM, Wu HB, Qiang Q. Association of differentially expressed genes with activation of mouse hepatic stellate cells by high-density cDNA microarray. World J Gastroenterol 2004;10:1600-1607.
33. Son G, Hines IN, Lindquist J, Schrum LW, Rippe RA. Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis. Hepatology 2009;50:1512-1523.
34. Huang JF, Chuang YH, Dai CY, Yu ML, Huang CF, Hsiao PJ, et al. Hepatic Akt expression correlates with advanced fibrosis in patients with chronic hepatitis C infection. Hepatol Res 2011;41:430-436.